The following Tax guidance note provides comprehensive and up to date legal information covering:
The EIS is designed to encourage investment in smaller, higher-risk trading companies by offering a range of tax reliefs to individual investors purchasing newly issued shares in those companies.
EIS allows unquoted companies (companies listed on AIM are unquoted for these purposes) that meet certain requirements to raise finance by issuing qualifying shares to qualifying investors. The EIS regime is prescriptive and sets out a number of requirements that must be met, including in relation to:
the individual investors
the issued shares, and
the issuing company
The income tax relief available to qualifying EIS investors is probably the best known of the tax reliefs. With the top rate of income tax at 45%, EIS investment is expected to continue to remain attractive to individuals seeking to mitigate their personal tax liabilities. This Practice Note describes this income tax relief as well as the various other tax reliefs available to individual investors qualifying for EIS relief. For information on other reliefs that may be relevant to investors in EIS, see Practice Note: Tax incentives for individuals investing in AIM companies.
For more details on the conditions that must be satisfied before such tax reliefs are available, see Practice Notes:
EIS—conditions for relief: individual investor conditions
EIS—conditions for relief: issued shares, the funds raised and the arrangements in general
EIS—conditions for relief: issuing company, and
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.